Genetic Testing to Determine Responses and Side Effects to Psychotropic Medications

Genetic testing as an additional measure to determine responses and side effects to psychotropic medications is now available in my private practice. The Genecept Assay is a simple, non-invasive, buccal test developped by Genomind. It analyzes ten genes shown to have implications for response to treatments used in depression, bipolar disorder, schizophrenia, anxiety disorders, OCD and ADHD. The analyzed genes target major hepatic enzymes and key neurotransmitter pathways including serotonin, dopamine and glutamate.


For more information or to schedule an appointment, call (917) 251-6498. 

Physical Activity Improves Depression and Decreases Schizophrenia Symptoms in Mentally ill Patients

In the 09/14 issue of the Journal of Clinical Psychiatry, Rosenbaum et al. conducted a meta-analysis on 39 randomized controlled trials of adults with mental illness other than dysthymia or eating disorders. They found that physical activity reduced symptoms depressive symptoms. Studies published in Chinese also suggest that physical activity may reduce negative and positive symptoms of schizophrenia. There was also a moderate effect of physical activity on quality of life. Most of the interventions were aerobic-based. Unfortunately, exercise protocols were poorly described in many of the studies and no particular protocol can be recommended a this time. There were no significant difference in depression outcome between studies using or not using the aerobic-training guidelines of the American College of Sports Medicine.